Navarrabiomed launches ReproNAGEN, an initiative that will analyze the whole genome of patients with fertility problems

The first meeting of the ReproNAGEN consortium was held last Friday at the headquarters of Navarrabiomed. This new initiative aims to study the impact of human genome analysis in the diagnosis and treatment of couples with fertility problems by creating a personalized diagnostic algorithm and a therapeutic circuit based on the study of the complete … Read more